74
Views
139
CrossRef citations to date
0
Altmetric
Article

The Association of Notch2 and NF-κB Accelerates RANKL-Induced Osteoclastogenesis

, , , , , , , & show all
Pages 6402-6412 | Received 22 Feb 2008, Accepted 11 Aug 2008, Published online: 27 Mar 2023

REFERENCES

  • Aguilera, C., R. Hoya-Arias, G. Haegeman, L. Espinosa, and A. Bigas. 2004. Recruitment of IκBα to the hes1 promoter is associated with transcriptional repression. Proc. Natl. Acad. Sci. USA 101:16537–16542.
  • Amsen, D., J. M. Blander, G. R. Lee, K. Tanigaki, T. Honjo, and R. A. Flavell. 2004. Instruction of distinct CD4 T helper cell fates by different notch ligands on antigen-presenting cells. Cell 117:515–526.
  • Artavanis-Tsakonas, S., M. D. Rand, and R. J. Lake. 1999. Notch signaling: cell fate control and signal integration in development. Science 284:770–776.
  • Asagiri, M., K. Sato, T. Usami, S. Ochi, H. Nishina, H. Yoshida, I. Morita, E. F. Wagner, T. W. Mak, E. Serfling, and H. Takayanagi. 2005. Autoamplification of NFATc1 expression determines its essential role in bone homeostasis. J. Exp. Med. 202:1261–1269.
  • Asagiri, M., and H. Takayanagi. 2007. The molecular understanding of osteoclast differentiation. Bone 40:251–264.
  • Bai, S., R. Kopan, W. Zou, M. J. Hilton, C. T. Ong, F. Long, F. P. Ross, and S. L. Teitelbaum. 2008. Notch1 regulates osteoclastogenesis directly in osteoclast precursors and indirectly via c-fos osteoblast lineage cells. J. Biol. Chem. 283:6509–6518.
  • Bigas, A., D. I. Martin, and L. A. Milner. 1998. Notch1 and Notch2 inhibit myeloid differentiation in response to different cytokines. Mol. Cell. Biol. 18:2324–2333.
  • Boyle, W. J., W. S. Simonet, and D. L. Lacey. 2003. Osteoclast differentiation and activation. Nature 423:337–342.
  • Bray, S. J. 2006. Notch signalling: a simple pathway becomes complex. Nat. Rev. Mol. Cell Biol. 7:678–689.
  • Bulman, M. P., K. Kusumi, T. M. Frayling, C. McKeown, C. Garrett, E. S. Lander, R. Krumlauf, A. T. Hattersley, S. Ellard, and P. D. Turnpenny. 2000. Mutations in the human delta homologue, DLL3, cause axial skeletal defects in spondylocostal dysostosis. Nat. Genet. 24:438–441.
  • Calvi, L. M., N. A. Sims, J. L. Hunzelman, M. C. Knight, A. Giovannetti, J. M. Saxton, H. M. Kronenberg, R. Baron, and E. Schipani. 2001. Activated parathyroid hormone/parathyroid hormone-related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone. J. Clin. Investig. 107:277–286.
  • Calvi, L. M., G. B. Adams, K. W. Weibrecht, J. M. Weber, D. P. Olson, M. C. Knight, R. P. Martin, E. Schipani, P. Divieti, F. R. Bringhurst, L. A. Milner, H. M. Kronenberg, and D. T. Scadden. 2003. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 23:841–846.
  • Deregowski, V., E. Gazzerro, L. Priest, S. Rydziel, and E. Canalis. 2006. Notch 1 overexpression inhibits osteoblastogenesis by suppressing Wnt/β-catenin but not bone morphogenetic protein signaling. J. Biol. Chem. 281:6203–6210.
  • Dougall, W. C., M. Glaccum, K. Charrier, K. Rohrbach, K. Brasel, T. De Smedt, E. Daro, J. Smith, M. E. Tometsko, C. R. Maliszewski, A. Armstrong, V. Shen, S. Bain, D. Cosman, D. Anderson, P. J. Morrissey, J. J. Peschon, and J. Schuh. 1999. RANK is essential for osteoclast and lymph node development. Genes Dev. 13:2412–2424.
  • Engin, F., Z. Yao, T. Yang, G. Zhou, T. Bertin, M. M. Jiang, Y. Chen, L. Wang, H. Zheng, R. E. Sutton, B. F. Boyce, and B. Lee. 2008. Dimorphic effects of Notch signaling in bone homeostasis. Nat. Med. 14:299–305.
  • Espinosa, L., S. Santos, J. Inglés-Esteve, P. Muñoz-Canoves, and A. Bigas. 2002. p65-NF-κB synergizes with Notch to activate transcription by triggering cytoplasmic translocation of the nuclear receptor corepressor N-CoR. J. Cell Sci. 115:1295–1303.
  • Espinosa, L., J. Inglés-Esteve, A. Robert-Moreno, and A. Bigas. 2003. IκBα and p65 regulate the cytoplasmic shuttling of nuclear corepressors: cross-talk between Notch and NF-κB pathways. Mol. Biol. Cell 14:491–502.
  • Franzoso, G., L. Carlson, L. Xing, L. Poljak, E. W. Shores, K. D. Brown, A. Leonardi, T. Tran, B. F. Boyce, and U. Siebenlist. 1997. Requirement for NF-κB in osteoclast and B-cell development. Genes Dev. 11:3482–3496.
  • Grigoriadis, A. E., Z. Q. Wang, M. G. Cecchini, W. Hofstetter, R. Felix, H. A. Fleisch, and E. F. Wagner. 1994. c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 266:443–448.
  • Han, H., K. Tanigaki, N. Yamamoto, K. Kuroda, M. Yoshimoto, T. Nakahata, K. Ikuta, and T. Honjo. 2002. Inducible gene knockout of transcription factor recombination signal binding protein-J reveals its essential role in T versus B lineage decision. Int. Immunol. 14:637–645.
  • Hilton, M. J., X. Tu, X. Wu, S. Bai, H. Zhao, T. Kobayashi, H. M. Kronenberg, S. L. Teitelbaum, F. P. Ross, R. Kopan, and F. Long. 2008. Notch signaling maintains bone marrow mesenchymal progenitors by suppressing osteoblast differentiation. Nat. Med. 14:306–314.
  • Hirano, F., H. Tanaka, Y. Hirano, M. Hiramoto, H. Handa, I. Makino, and C. Sheidereit. 1998. Functional interference of Sp1 and NF-κB through the same DNA binding site. Mol. Cell. Biol. 18:1266–1274.
  • Hrabe de Angelis, M., J. I. I. McIntyre, and A. Gossler. 1997. Maintenance of somite borders in mice requires the Delta homologue DII1. Nature 386:717–721.
  • Ikeda, F., R. Nishimura, T. Matsubara, S. Tanaka, J. Inoue, S. V. Reddy, K. Hata, K. Yamashita, T. Hiraga, T. Watanabe, T. Kukita, K. Yoshioka, A. Rao, and T. Yoneda. 2004. Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation. J. Clin. Investig. 114:475–484.
  • Iotsova, V., J. Caamaño, J. Loy, Y. Yang, A. Lewin, and R. Bravo. 1997. Osteopetrosis in mice lacking NF-κB1 and NF-κB2. Nat. Med. 3:1285–1289.
  • Karanu, F. N., B. Murdoch, T. Miyabayashi, M. Ohno, M. Koremoto, L. Gallacher, D. Wu, A. Itoh, S. Sakano, and M. Bhatia. 2001. Human homologues of Delta-1 and Delta-4 function as mitogenic regulators of primitive human hematopoietic cells. Blood 97:1960–1967.
  • Kitamura, T., Y. Koshino, F. Shibata, T. Oki, H. Nakajima, T. Nosaka, and H. Kumagai. 2003. Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics. Exp. Hematol. 31:1007–1014.
  • Koga, T., M. Inui, K. Inoue, S. Kim, A. Suematsu, E. Kobayashi, T. Iwata, H. Ohnishi, T. Matozaki, T. Kodama, T. Taniguchi, H. Takayanagi, and T. Takai. 2004. Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature 428:758–763.
  • Kong, Y. Y., H. Yoshida, I. Sarosi, H. L. Tan, E. Timms, C. Capparelli, S. Morony, A. J. Oliveira-dos-Santos, G. Van, A. Itie, W. Khoo, A. Wakeham, C. R. Dunstan, D. L. Lacey, T. W. Mak, W. J. Boyle, and J. M. Penninger. 1999. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397:315–323.
  • Kusumi, K., E. S. Sun, A. W. Kerrebrock, R. T. Bronson, D. C. Chi, M. S. Bulotsky, J. B. Spencer, B. W. Birren, W. N. Frankel, and E. S. Lander. 1998. The mouse pudgy mutation disrupts Delta homologue Dll3 and initiation of early somite boundaries. Nat. Genet. 19:274–278.
  • Lee, S. H., X. Wang, and J. DeJong. 2000. Functional interactions between an atypical NF-κB site from the rat CYP2B1 promoter and the transcriptional repressor RBP-J.κ/CBF1. Nucleic Acids Res. 28:2091–2098.
  • Li, J. P., H. Kajiya, F. Okamoto, A. Nakao, T. Iwamoto, and K. Okabe. 2007. Three Na+/Ca2+ exchanger (NCX) variants are expressed in mouse osteoclasts and mediate calcium transport during bone resorption. Endocrinology 148:2116–2125.
  • Li, L., L. A. Milner, Y. Deng, M. Iwata, A. Banta, L. Graf, S. Marcovina, C. Friedman, B. J. Trask, L. Hood, and B. Torok-Storb. 1998. The human homolog of rat Jagged1 expressed by marrow stroma inhibits differentiation of 32D cells through interaction with Notch1. Immunity 8:43–55.
  • Lindsell, C. E., J. Boulter, G. diSibio, A. Gossler, and G. Weinmaster. 1996. Expression patterns of Jagged, Delta1, Notch1, Notch2, and Notch3 genes identify ligand-receptor pairs that may function in neural development. Mol. Cell. Neurosci. 8:14–27.
  • Mastrangelo, P., P. M. Mathews, M. A. Chishti, S. D. Schmidt, Y. Gu, J. Yang, M. J. Mazzella, J. Coomaraswamy, P. Horne, B. Strome, H. Pelly, G. Levesque, C. Ebeling, Y. Jiang, R. A. Nixon, R. Rozmahel, P. E. Fraser, P. St. George-Hyslop, G. A. Carlson, and D. Westaway. 2005. Dissociated phenotypes in presenilin transgenic mice define functionally distinct γ-secretases. Proc. Natl. Acad. Sci. USA 102:8972–8977.
  • McCright, B., X. Gao, L. Shen, J. Lozier, Y. Lan, M. Maguire, D. Herzlinger, G. Weinmaster, R. Jiang, and T. Gridley. 2001. Defects in development of the kidney, heart and eye vasculature in mice homozygous for a hypomorphic Notch2 mutation. Development 128:491–502.
  • McCright, B., J. Lozier, and T. Gridley. 2002. A mouse model of Alagille syndrome: Notch2 as a genetic modifier of Jag1 haploinsufficiency. Development 129:1075–1082.
  • McDaniell, R., D. M. Warthen, P. A. Sanchez-Lara, A. Pai, I. D. Krantz, D. A. Piccoli, and N. B. Spinner. 2006. NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the Notch signaling pathway. Am. J. Hum. Genet. 79:169–173.
  • Moreno, A. R., J. Guiu, C. Ruiz-Herguido, M. E. López, J. Inglés-Esteve, L. Riera, A. Tipping, T. Enver, E. Dzierzak, T. Gridley, L. Espinosa, and A. Bigas. 5 June 2008. Impaired embryonic haematopoiesis yet normal arterial development in the absence of the Notch ligand Jagged1. EMBO J. doi:10.1038/emboj.2008.113.
  • Nair, P., K. Somasundaram, and S. Krishna. 2003. Activated Notch1 inhibits p53-induced apoptosis and sustains transformation by human papillomavirus type 16 E6 and E7 oncogenes through a PI3K-PKB/Akt-dependent pathway. J. Virol. 77:7106–7112.
  • Naito, A., S. Azuma, S. Tanaka, T. Miyazaki, S. Takaki, K. Takatsu, K. Nakao, K. Nakamura, M. Katsuki, T. Yamamoto, and J. Inoue. 1999. Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice. Genes Cells 4:353–362.
  • Nickoloff, B. J., J. Z. Qin, V. Chaturvedi, M. F. Denning, B. Bonish, and L. Miele. 2002. Jagged-1 mediated activation of notch signaling induces complete maturation of human keratinocytes through NF-κB and PPARγ. Cell Death Differ. 9:842–855.
  • Nobta, M., T. Tsukazaki, Y. Shibata, C. Xin, T. Moriishi, S. Sakano, H. Shindo, and A. Yamaguchi. 2005. Critical regulation of bone morphogenetic protein-induced osteoblastic differentiation by Delta1/Jagged1-activated Notch1 signaling. J. Biol. Chem. 280:15842–15848.
  • Nosaka, T., T. Kawashima, K. Misawa, K. Ikuta, A. L. Mui, and T. Kitamura. 1999. STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells. EMBO J. 18:4754–4765.
  • Oswald, F., S. Liptay, G. Adler, and R. M. Schmid. 1998. NF-κB2 is a putative target gene of activated Notch-1 via RBP-J.κ. Mol. Cell. Biol. 18:2077–2088.
  • Sato, K., A. Suematsu, T. Nakashima, S. Takemoto-Kimura, K. Aoki, Y. Morishita, H. Asahara, K. Ohya, A. Yamaguchi, T. Takai, T. Kodama, T. A. Chatila, H. Bito, and H. Takayanagi. 2006. Regulation of osteoclast differentiation and function by the CaMK-CREB pathway. Nat. Med. 12:1410–1416.
  • Sciaudone, M., E. Gazzerro, L. Priest, A. M. Delany, and E. Canalis. 2003. Notch 1 impairs osteoblastic cell differentiation. Endocrinology 144:5631–5639.
  • Shen, J., R. T. Bronson, D. F. Chen, W. Xia, D. J. Selkoe, and S. Tonegawa. 1997. Skeletal and CNS defects in presenilin-1-deficient mice. Cell 16:629–639.
  • Shin, H. M., L. M. Minter, O. H. Cho, S. Gottipati, A. H. Fauq, T. E. Golde, G. E. Sonenshein, and B. A. Osborne. 2006. Notch1 augments NF-κB activity by facilitating its nuclear retention. EMBO J. 25:129–138.
  • Small, D., D. Kovalenko, D. Kacer, L. Liaw, M. Landriscina, C. Di Serio, I. Prudovsky, and T. Maciag. 2001. Soluble Jagged 1 represses the function of its transmembrane form to induce the formation of the Src-dependent chord-like phenotype. J. Biol. Chem. 276:32022–32030.
  • Small, D., D. Kovalenko, R. Soldi, A. Mandinova, V. Kolev, R. Trifonova, C. Bagala, D. Kacer, C. Battelli, L. Liaw, I. Prudovsky, and T. Maciag. 2003. Notch activation suppresses fibroblast growth factor-dependent cellular transformation. J. Biol. Chem. 278:16405–16413.
  • Song, L. L., Y. Peng, J. Yun, P. Rizzo, V. Chaturvedi, S. Weijzen, W. M. Kast, P. J. Stone, L. Santos, A. Loredo, U. Lendahl, G. Sonenshein, B. Osborne, J. Z. Qin, A. Pannuti, B. J. Nickoloff, and L. Miele. 16 June 2008. Notch-1 associates with IKKα and regulates IKK activity in cervical cancer cells. Oncogene doi:10.1038/onc.2008.190.
  • Swiatek, P. J., C. E. Lindsell, F. F. del Amo, G. Weinmaster, and T. Gridley. 1991. Notch1 is essential for postimplantation development in mice. Genes Dev. 113:707–719.
  • Takahashi, N., N. Udagawa, S. Tanaka, and T. Suda. 2003. Generating murine osteoclasts from bone marrow. Methods Mol. Med. 80:129–144.
  • Takayanagi, H., S. Kim, T. Koga, H. Nishina, M. Isshiki, H. Yoshida, A. Saiura, M. Isobe, T. Yokochi, J. Inoue, E. F. Wagner, T. W. Mak, T. Kodama, and T. Taniguchi. 2002. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell 3:889–901.
  • Teitelbaum, S. L. 2000. Bone resorption by osteoclasts. Science 289:1504–1508.
  • Tezuka, K., M. Yasuda, N. Watanabe, N. Morimura, K. Kuroda, S. Miyatani, and N. Hozumi. 2002. Stimulation of osteoblastic cell differentiation by Notch. J. Bone Miner. Res. 17:231–239.
  • Vacca, A., M. P. Felli, R. Palermo, G. Di Mario, A. Calce, M. Di Giovine, L. Frati, A. Gulino, and I. Screpanti. 2006. Notch3 and pre-TCR interaction unveils distinct NF-κB pathways in T-cell development and leukemia. EMBO J. 25:1000–1008.
  • Weijzen, S., M. P. Velders, A. G. Elmishad, P. E. Bacon, J. R. Panella, B. J. Nickoloff, L. Miele, and W. M. Kast. 2002. The Notch ligand Jagged-1 is able to induce maturation of monocyte-derived human dendritic cells. J. Immunol. 169:4273–4278.
  • Weinmaster, G., V. J. Roberts, and G. Lemke. 1991. A homolog of Drosophila Notch expressed during mammalian development. Development 113:199–205.
  • Xue, Y., X. Gao, C. E. Lindsell, C. R. Norton, B. Chang, C. Hicks, M. Gendron-Maguire, E. B. Rand, G. Weinmaster, and T. Gridley. 1999. Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1. Hum. Mol. Genet. 8:723–730.
  • Yamada, T., H. Yamazaki, T. Yamane, M. Yoshino, H. Okuyama, M. Tsuneto, T. Kurino, S. Hayashi, and S. Sakano. 2003. Regulation of osteoclast development by Notch signaling directed to osteoclast precursors and through stromal cells. Blood 15:2227–2234.
  • Zamurovic, N., D. Cappellen, D. Rohner, and M. Susa. 2004. Coordinated activation of notch, Wnt, and transforming growth factor-beta signaling pathways in bone morphogenic protein 2-induced osteogenesis. Notch target gene Hey1 inhibits mineralization and Runx2 transcriptional activity. J. Biol. Chem. 279:37704–37715.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.